<DOC>
	<DOCNO>NCT00095446</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . The aim trial ass control blood sugar , safety , patient acceptance insulin aspart compare insulin lispro , insulin pump , standard clinical practice .</brief_summary>
	<brief_title>NovoLog Observation Trial Subjects With Type 1 Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>People Type I Type II Diabetes 18 Years Older .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Diabetes</keyword>
</DOC>